The Coronavirus Preparedness and Response Supplemental Appropriations Act
H.R. 6074, The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, March 6, 2020 provided $8.3 billion in FY 2020 emergency supplemental appropriations to combat COVID-19, allowed for broad waiver of Medicare telehealth restrictions.
CMS agreed language was inadequate and was readdressed in 2nd supplemental package H.R. 6201. The $8.3 billion is divided into $7.8 billion in discretionary appropriations and $500 million in mandatory spending for "Medicare telehealth mandatory spending. Broken down by category, the bill provides funding for the following purposes:
$3 billion for "research and development of vaccines, as well as therapeutics and diagnostics"
$2.2 billion "in public health funding to aid in prevention, preparedness and response efforts — including $950 million to support state and local agencies"
Almost $1 billion for "medical supplies, health-care preparedness, Community Health Centers and medical surge capacity"
$1.25 billion to fight coronavirus internationally.